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Abstract 
BACKGROUND: Several studies have indicated the increasing risk of active tuberculosis (TB) due to diabetes 
mellitus (DM). The increasing prevalence of DM in areas with endemic TB may adversely influence spreading of TB. 
The current study is undertaken aiming to assess the prevalence of DM in patients with pulmonary TB. 
METHODS: This case control study was conducted on 522 participants during a period of 12 years from  
2004-2016 in Qom city, central Iran. The control group was symptomatic respiratory patients without preceding 
history of active pulmonary TB in the same clinic (n = 261). The case and control groups were compared using the 
Chi-square test. In addition, adjusted odds ratios (OR) and 95% confidence interval for comparison of the DM 
prevalence among patients with TB across different groups were calculated by multivariate logistic regression. 
RESULTS: Mean age of the case and control patients were 51.0 ± 20.5 and 54.0 ± 14.9 years, respectively and 
40.4% of all participants were males. The prevalence of DM was higher in patients with TB compared to the control 
patients and the rate was found to be 26.5% with adjusted OR of 3.54. The DM prevalence was significantly 
associated with TB in patients with older age (P < 0.001). 
CONCLUSION: The prevalence of DM is significantly higher among patients with TB compared to the general 
population. Moreover, the mean age of patients with TB with DM is significantly higher than expected in patients 
with TB without DM. 
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Introduction1 
Tuberculosis (TB), an air born infection caused 
by Mycobacterium Tuberculosis, is a major global 
health concern. It infects millions of people each 
year and is the second deadly infectious disease 
worldwide, after the human immunodeficiency 
virus (HIV).1 It has been estimated that in 2017, 
10 million new cases were diagnosed 
worldwide, the majority (95%) of whom living 
in the low and middle income regions. 
However, the number of TB deaths and 
incidence rate continuously fall globally.1 The 
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incidence rate of TB in Iran is 16 cases per 
100000 population and at present, 16,000 people 
suffer from the disease. Moreover, the annual 
death rate due to TB is 2000 among Iranians.2 
Diabetes mellitus (DM) describes a group of 
metabolic disorders characterized by increased 
blood glucose concentration. DM is a mainly 
asymptomatic disease, as a result it is 
diagnosed in late stages. The global prevalence 
of DM in adults has been increased over the 
recent decades following population aging, 
urbanization, alteration of diet, and reduction 
of physical activity patterns leading to 
increasing obesity.  
The main portion (≃ 80%) of the 415 million 
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middle income countries. It has been proposed 
that the DM prevalence will be exponentially 
increased in regions with high TB incidence 
over the next 30 years.3 In 2011, impaired 
fasting glucose and total DM prevalence rates 
were 14.60% and 11.37% among Iranian adults, 
respectively. Moreover, in 2005-2011, trend 
analysis revealed a 35.1% increase in DM 
prevalence in Iran.4 
Several risk factors are involved in prevalence 
and incidence of TB, including age, gender, 
asthma, smoking habits, and family history of 
contact with patients with TB. People with 
suppressed immune system are susceptible to 
developing the latent to active TB. Factors such 
as poverty, homelessness, wars, immigration, 
malnutrition, renal insufficiency, alcoholism, 
social disorders, HIV infection, and especially 
DM play significant roles in growth of TB rates.  
The risk of progression of latent to active TB 
in patients with DM is 2-3 times higher than in 
subjects without DM.5 A study using dynamic 
TB transmission models to analyze the 
potential effects of DM on TB epidemiology in 
13 countries with high burden of TB 
determined that stopping the growth of DM 
would decrease almost six million incidence of 
TB and more than one million TB deaths in 20 
years.6 Therefore, it is of crucial importance to 
evaluate the prevalence of DM and its 
contribution to TB. Furthermore, DM may 
negatively influence TB treatment outcomes in 
patients with active TB, by delaying the time 
for microbiological response, decreasing the 
chance of favorable consequences, growing the 
risk of relapse, deaths, and drug resistance.7 
The prevalence of DM has been elevated in 
developing countries where TB is highly 
endemic. As a result, the co-incidence of DM and 
TB has been increased, warning about emerging 
concern in this field.8 Therefore, the current 
study was designed to assess the prevalence rate 
of DM in patients with pulmonary TB. 
Materials and Methods 
This case control study was carried out in Qom 
City located in central Iran (34°38′24″N 
50°52′35″E). Medical records of 1500 patients 
suffering from pulmonary TB during a period 
of 12 years (April 2004 to March 2016) referred 
to Tuberculosis and Leprosy Control Office of 
Communicable Disease Management Center 
were analyzed. Pulmonary TB cases were 
defined based on the World Health 
Organization (WHO) and Iranian national TB 
guidelines. According to the guidelines, at least 
three sputum samples should be taken from the 
suspected cases of pulmonary TB in the early 
morning and sent for TB microscopy and 
culture before starting possible treatments. 
Spontaneously produced sputum is preferred, if 
it is not possible, induction of sputum or 
bronchoalveolar lavage (BAL) should be used. 
A case of pulmonary TB is considered to be 
smear-positive if 1-9 bacilli are observed in each 
microscopic field and graded as 1+, 2+, and 3+. 
In smear negative pulmonary TB, no bacilli can 
be seen in microscopic field, but growth is 
positive in cultures or radiological findings are 
consistent with active pulmonary TB.9 
DM was defined based on the diagnostic 
criteria described by the American Diabetes 
Association (ADA) as follows: 
A fasting plasma glucose (FPG) level of 126 
mg/dl or higher, a two-hour plasma glucose 
level of 200 mg/dl or higher during a 75-g oral 
glucose tolerance test (OGTT), or a random 
plasma glucose of 200 mg/dl or higher in a 
patients with classic symptoms of 
hyperglycemia or hyperglycemic crisis.10 
The study inclusion criteria included 
pulmonary TB and age above 15 years old. The 
exclusion criteria included HIV positive 
patients, intravenous (IV) drug abuser, previous 
history of gastric bypass surgery, end stage 
renal disease (ESRD), cancer, leukemia and 
lymphoma, immunocompromised patients, and 
patients on oral corticosteroid or 
immunosuppressant drugs. The control group 
were symptomatic respiratory patients from the 
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active pulmonary TB who matched to the same 
age and gender subcategory in the case group. 
Considering the inclusion and exclusion 
criteria, finally 261 patients with TB as the case 
subjects and 261 symptomatic respiratory 
patients as the control subjects were selected for 
the study. The sociodemographic parameters 
were monthly family income (minimum, 
medium, and high wage), marital status (single, 
married), age, gender, nationality, residency 
(urban, rural), education (undergraduate, 
graduate), and body mass index (BMI).  
All the information obtained was kept 
confidential. The study was initiated after the 
approval from the Ethics Review and Research 
Committee, Islamic Azad University. 
Permission from the health authorities was 
also taken prior to the study. 
Descriptive statistics including mean and 
standard deviation (mean ± SD) were used to 
present data. Comparisons between groups 
were made using the Chi-square test or 
Fisher’s exact test as appropriate for 
qualitative/categorical variables. Multivariate 
logistic regression was used to calculate 
adjusted odds ratios (OR) and 95% confidence 
intervals for comparison of DM prevalence 
among patients with TB across different 
subgroups. A two-way analysis of variance 
(ANOVA-2) was performed for assessing the 
effects of demographic parameters and 
grouping (case and control) on the level of 
fasting blood sugar (FBS). Data analyses were 
performed using Statistical Package for Social 
Science (SPSS) (version 20, IBM Corporation, 
Armonk, NY, USA) and P values less than 
0.050 was considered significant.  
Results 
Table 1 represents the demographic data and 
characteristics of the participants. As can be 
seen, mean age of the case and control patients 
were 51.0 ± 20.5 and 54.0 ± 14.9 years old, 
respectively (P < 0.180). Moreover, 44.1% of the 
patients with TB and 41% of the patients in the 
control group had age less than 50 years old. 
Furthermore, 37.5% of the case group and 
43.3% of the control group were comprised of 
men. The proportion of the patients with TB 
with BMI < 25 was 18.3%, and more than 80% 
of the participants were Iranians the majority 
(90.4%) of who were urban residents.  
 
Table 1. Demographic data and characteristics of the participants 
Variable Group Case (%) Control (%) Total (%) P 
Gender Male 98 (37.5) 113 (43.3) 211(40.4) 0.180 
Female 163 (62.5) 148 (56.7) 311 (59.6) 
Nationality Domestic 165 (63.2) 256 (98.5) 422 (80.8) < 0.001 
Foreigner 96(36.8) 5(1.5) 100(19.2) 
Residency Urban 233 (89.3) 239 (91.6) 472 (90.4) 0.370 
Rural 28 (12.3) 22 (8.4) 50 (10.1) 
Marriage Single 54 (20.7) 39 (14.9) 93 (17.8) 0.086 
Married 207 (79.3) 222 (85.1) 429 (82.2) 
Education  Undergraduate 226 (86.6) 194 (74.3) 420 (80.5) < 0.001 
Graduated 35 (13.4) 67 (25.7) 102(19.5) 
Income Low 181 (69.3) 139 (53.3) 320(61.3) < 0.001 
Medium  70 (26.8) 63 (24.1) 133(25.5) 
High 10 (3.8) 59 (22.6) 69(13.2) 
Age (years) Below 50 115 (44.1) 107 (41.0) 222 (42.5) 0.470 
Above 50 146 (55.9) 154 (59.0) 300 (57.5) 
BMI Below 25 48 (18.3) 42 (16.0) 90 (17.2) 0.480 
Above 25 213 (81.7) 219 (84.0) 432 (82.8) 
FBS (mg/dl) Below 100 117 (44.8) 202 (77.3) 319 (61.1) < 0.001 
Between 100-126 75 (28.7) 27 (10.3) 102 (19.6) 
Above 126 69 (26.5) 32 (12.4) 101 (19.3) 
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Table 2. Comparison of diabetes mellitus (DM) prevalence among patients with tuberculosis (TB)  
across different groups 
Variable Categories TB (%) TB + DM Prevalence 
(%) 
OR 95% CI P 
Age (years) < 50 115 (44.1) 10 8.7 7.14 3.43-14.70 < 0.001 
> 50 146 (55.9) 59 40.4 
Gender Male 98 (37.5) 22 22.4 1.40 0.78-2.50 0.250 
Female 163 (62.5) 47 28.8 
Nationality Iranian 165 (63.2) 54 32.7 2.62 1.38-4.98 0.003 
Foreigner 96 (36.8) 15 15.6 
BMI < 25 48 (18.4) 12 25.0 1.09 0.53-2.25 0.800 
> 25 213 (81.6) 57 26.8 
Marital status Single 54 (20.7) 10 18.5 1.75 0.82-3.71 0.130 
Married 207 (79.3) 59 28.5 
Residency   Urban 233 (89.3) 64 27.5 0.57 0.20-1.57 0.270 
Rural 28 (10.7) 5 17.9 
Education  Undergraduate 226 (86.6) 60 26.5 0.95 0.42-2.16 0.910 
Graduated 35 (13.4) 9 25.7 
Income Low 181 (69.3) 49 27.1 1.01 0.61-1.66 0.480 
Medium 70 (26.8) 16 22.9 
High 10 (3.8) 4 40.0 
TB: Tuberculosis; DM: Diabetes mellitus; OR: Odd ratio; CI: Confident interval; BMI: Body mass index 
 
The frequency of DM was higher in patients 
with TB compared to those in the control 
group. 69 of the patients with TB and 32 of the 
control ones had DM and the prevalence of 
DM in the case and control groups were found 
to be 26.5% and 12.4%, respectively [P < 0.001, 
crude OR = 2.57 (1.62-4.07), adjusted OR = 3.54 
(2.13-5.88)]. Consistently, mean of FBS in the 
patients with TB and the control individuals 
was 125.2 ± 57.5 and 99.8 ± 33.6 mg/dl  
(P < 0.001), respectively.  
Comparing the DM prevalence among 
various subcategories of patients with TB 
described in table 2 revealed that significant 
differences were present among only the two 
demographic variable of age [crude OR = 7.14, 
(3.43-14.7) with adjusted OR = 6.77 (3.25-14.1) 
and nationality [crude OR = 2.62, (1.38-4.98) 
with adjusted OR = 2.36 (1.20-4.63)]. 
ANOVA-2 was conducted to examine the 
effects of demographic parameters and 
grouping (case and control) on the level of 
FBS and statistically significant interaction 
was noticed only between the age and 
grouping (F = 16.20, P < 0.001). This means 
that FBS was significantly higher in patients 
with TB with the age of more than 50 years 
old (Table 3). 
Discussion 
In the current study, the prevalence of DM in 
patients with TB was found to be 26.5% which 
was higher than that in the control group 
(12.4%) with OR more than 3. Similar findings 
have been reported by other researchers.11,12 
The association between TB and DM has 
previously been confirmed and several 
epidemiologic studies have reported a 
significant correlation in this regard,13,14 
Patients with DM are at 2-3 folds higher risk of 
developing active TB compared to the general 
population.15 A systematic review of  
13 observational studies demonstrated that 
DM was associated with an increased risk of 
TB [relative risk = 3.11, 95% confidence 
interval (CI) 2.27-4.26] and case-control studies 
were heterogeneous with ORs of 1.16 to 7.83.16 
Additionally, systematic review of the 
literature determined that in the top 10 
countries with the highest prevalence of TB, 
12.6% (95% CI 9.2-17.3) of the new cases had to 
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Table 3. Comparison of fasting blood sugar (FBS) level among the case  
and control subjects in different groups 
Variable Categories TB Control P 
FBS (mean ± SD) FBS (mean ±SD) 
Age (years) < 50 105.4 ± 47.6 98.0 ± 32.0 < 0.001 
> 50 140.8 ± 59.8 101.0 ± 34.0 
Gender Male 119.3 ± 48.7 99.6 ± 35.4 0.270 
Female 128.8 ± 62 99.9 ± 32.3 
Nationality Iranian 131.2 ± 60.4 100.0 ± 33.8 0.860 
Foreigner 114.9 ± 50.6 87.7 ± 14.2 
BMI < 25 121.3 ± 49.5 96.0 ± 23.6 0.980 
> 25 126.1 ± 59.2 100.5 ± 35.2 
Marriage Single 116.2 ± 58.9 98.3 ± 25.4 0.380 
Married 127.5 ± 57 100.1 ± 34.9 
Residency Urban 127.1 ± 59.4 99.1 ± 32.4 0.059 
Rural 109.2 ± 34.2 107.7 ± 44.8 
Education Undergraduate 125.1 ± 56.4 99.3 ± 34.8 0.930 
Graduated 126.1 ± 64.6 101.3 ± 30.3 
Income Low 125.7 ± 56.8 99.0 ± 32.8 0.700 
Medium 122.4 ± 59.6 101.5 ± 41.2 
High 135.9 ± 53.7 100.4 ± 27.8 
TB: Tuberculosis; FBS: Fasting blood sugar; SD: Standard deviation; BMI: Body mass index 
 
The present study findings showed a 
significantly higher prevalence of DM in older 
patients with TB with an OR of more than 7 for 
the age of above 50 years old. In support of this 
finding, it has been claimed that type 2 DM 
appears to be a critical risk for the onset of TB, 
particularly for adults in their 40s and early 
50s, the period which coincides with the onset 
of type 2 DM in the general population.18,19 
Despite the improvement of health care 
services, better living conditions, and changing 
life styles, the prevalence of DM is rising. 
Continuous screening and distinguishing of 
pre-diabetic stage play an important role in the 
reduction of TB incidence. 
Contrary to other studies, higher BMI was 
not observed in patients with TB and DM 
compared patients without DM with TB in this 
study.18 However, few other studies have 
shown a lower BMI in patients with DM.20 The 
current findings suggest that screening for DM 
is necessary in patients with TB even in case of 
the lack of a high BMI among them. 
Several studies have offered convincing 
biological evidence in support of the causal 
association between DM and impaired host 
immunity for TB activation.21,22 It has been 
demonstrated that the expression of adaptive 
immunity is delayed in chronic diabetic mice 
compared to euglycemic mice. This is 
evidenced by declined early production of 
gamma interferon (IFN-γ) and interleukin-12 
(IL-12) in the lung and the presence of fewer 
M. tuberculosis antigen early secreted antigen 6 
kilodaltons (ESAT-6)-responsive T cells within 
the first month of infection, marking a 
diminished T helper 1 (Th1) adaptive 
immunity; this plays a crucial role in 
controlling TB infection.23 In another study, to 
investigate the immune cell profile alterations 
in patients with TB with type 2 DM, it was 
noticed that patients with TB with coincident 
type 2 DM had higher percentages of Th2 and 
Th17 cells after stimulation with TB antigens, 
while they had unchanged Th1 cells and 
decreased CD8+ cytotoxic T cells compared to 
patients with TB without type 2 DM.24 
This study was constructed on the data 
obtained from observational studies which 
could be confounded by variables associated 
with both DM and TB. To decrease the 
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parameters of sociodemographic status with 
the application of adjustment. However, the 
samples were representative of the population 
with definite TB, because all the patients  
were registered at one of the reference TB 
centers in Qom.  
Conclusion 
In summary, the current findings indicate that 
the prevalence of DM is significantly higher in 
patients with TB. DM can activate latent TB by 
suppressing immune system, therefore, people 
with DM, especially the elderly, may be 
important targets for assessment for active case 
finding and management of latent TB and 
efforts to diagnose, detect, and treat DM may 
have a beneficial impact on the control of TB. 
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